The pathogenesis of mesothelioma

Michele Carbone1, Robert A Kratzke, Joseph R Testa

  • 1Cancer Immunology Program, Cardinal Bernardin Cancer Center, Department of Pathology, Loyola University Chicago, USA.

Seminars in Oncology
|February 12, 2002
PubMed

Insights

Malignant mesothelioma is linked to asbestos exposure, but Simian virus 40 (SV40) may also play a role. Asbestos and SV40 might act as co-carcinogens, contributing to mesothelioma development alongside genetic and environmental factors.

Area of Science:

  • Oncology
  • Virology
  • Environmental Health

Background:

  • Malignant mesothelioma (MM) is strongly associated with asbestos exposure, yet not all exposed individuals develop the disease.
  • Simian virus 40 (SV40), a DNA tumor virus, has been detected in human mesotheliomas and induces mesothelioma in hamsters.

Purpose of the Study:

  • To investigate the potential role of SV40 and its interaction with asbestos in the pathogenesis of malignant mesothelioma.
  • To explore the complex etiology of mesothelioma, including viral, environmental, and genetic factors.

Main Methods:

  • Detection of SV40 in human mesotheliomas.
  • In vitro studies on SV40-mediated transformation of human mesothelial cells.
  • Analysis of genetic mutations (p53, p16, p14ARF, NF2) and known environmental cofactors (erionite).

Main Results:

  • SV40 large tumor antigen is expressed in mesothelioma cells, and its inhibition halts tumor cell growth in vitro.
  • SV40 T-antigen binds and inhibits key cellular proteins (p53, Rb-family).
  • Asbestos exposure appears to enhance SV40-mediated transformation of human mesothelial cells, suggesting a co-carcinogenic effect.

Conclusions:

  • SV40 is implicated in mesothelioma pathogenesis, potentially acting as a co-carcinogen with asbestos.
  • Mesothelioma etiology is multifactorial, involving a complex interplay of environmental agents, viruses, and genetic predispositions.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are: